Literature DB >> 12559952

Characterization of KIBRA, a novel WW domain-containing protein.

Joachim Kremerskothen1, Christian Plaas, Katrin Büther, Indra Finger, Stefan Veltel, Theodoros Matanis, Thomas Liedtke, Angelika Barnekow.   

Abstract

In a yeast two hybrid screen with the human isoform of Dendrin (KIAA0749), a putative modulator of the postsynaptic cytoskeleton, we isolated a cDNA coding for a novel protein, KIBRA, possessing two amino-terminal WW domains, an internal C2-like domain and a carboxy-terminal glutamic acid-rich stretch. Northern blot analysis revealed that the expression of KIBRA mRNA was predominately found in kidney and brain. In vitro interaction studies revealed that the first KIBRA WW domain binds specifically to PPxY motifs. Transient transfection of monkey kidney cells with constructs encoding Myc-tagged KIBRA displayed a cytoplasmic localization and a perinuclear enrichment of the protein.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12559952     DOI: 10.1016/s0006-291x(02)02945-5

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  63 in total

1.  DWWA, a novel protein containing two WW domains and an IQ motif, is required for scission of the residual cytoplasmic bridge during cytokinesis in Dictyostelium.

Authors:  Akira Nagasaki; Taro Q P Uyeda
Journal:  Mol Biol Cell       Date:  2003-10-31       Impact factor: 4.138

Review 2.  Genetic architecture of declarative memory: implications for complex illnesses.

Authors:  Carrie E Bearden; Katherine H Karlsgodt; Peter Bachman; Theo G M van Erp; Anderson M Winkler; David C Glahn
Journal:  Neuroscientist       Date:  2011-08-10       Impact factor: 7.519

3.  Allelic variation of calsyntenin 2 (CLSTN2) modulates the impact of developmental tobacco smoke exposure on mnemonic processing in adolescents.

Authors:  Leslie K Jacobsen; Marina R Picciotto; Christopher J Heath; W Einar Mencl; Joel Gelernter
Journal:  Biol Psychiatry       Date:  2008-12-05       Impact factor: 13.382

4.  KIBRA modulates directional migration of podocytes.

Authors:  Kerstin Duning; Eva-Maria Schurek; Marc Schlüter; Michael Bayer; Hans-Christian Reinhardt; Albrecht Schwab; Liliana Schaefer; Thomas Benzing; Bernhard Schermer; Moin A Saleem; Tobias B Huber; Sebastian Bachmann; Joachim Kremerskothen; Thomas Weide; Hermann Pavenstädt
Journal:  J Am Soc Nephrol       Date:  2008-07-02       Impact factor: 10.121

5.  Peripheral delivery of a ROCK inhibitor improves learning and working memory.

Authors:  Matthew J Huentelman; Dietrich A Stephan; Joshua Talboom; Jason J Corneveaux; David M Reiman; Jill D Gerber; Carol A Barnes; Gene E Alexander; Eric M Reiman; Heather A Bimonte-Nelson
Journal:  Behav Neurosci       Date:  2009-02       Impact factor: 1.912

6.  Cognitive flexibility is associated with KIBRA variant and modulated by recent tobacco use.

Authors:  Huiping Zhang; Henry R Kranzler; James Poling; Jeffrey R Gruen; Joel Gelernter
Journal:  Neuropsychopharmacology       Date:  2009-07-15       Impact factor: 7.853

Review 7.  Hippo signaling in the kidney: the good and the bad.

Authors:  Jenny S Wong; Kristin Meliambro; Justina Ray; Kirk N Campbell
Journal:  Am J Physiol Renal Physiol       Date:  2016-05-18

8.  KIBRA regulates aurora kinase activity and is required for precise chromosome alignment during mitosis.

Authors:  Lin Zhang; Jyoti Iyer; Aparajita Chowdhury; Ming Ji; Ling Xiao; Shuping Yang; Yuanhong Chen; Ming-Ying Tsai; Jixin Dong
Journal:  J Biol Chem       Date:  2012-08-17       Impact factor: 5.157

9.  Kibra is a regulator of the Salvador/Warts/Hippo signaling network.

Authors:  Alice Genevet; Michael C Wehr; Ruth Brain; Barry J Thompson; Nicolas Tapon
Journal:  Dev Cell       Date:  2010-02-16       Impact factor: 12.270

10.  An aPKC-exocyst complex controls paxillin phosphorylation and migration through localised JNK1 activation.

Authors:  Carine Rosse; Etienne Formstecher; Katrina Boeckeler; Yingming Zhao; Joachim Kremerskothen; Michael D White; Jacques H Camonis; Peter J Parker
Journal:  PLoS Biol       Date:  2009-11-03       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.